| - GRCh37:
- Chr2:179485158-179485159
- GRCh38:
- Chr2:178620431-178620432
| TTN | C12795fs, C13722fs, C15363fs, C6298fs, C6423fs, C6490fs | Cardiomyopathy | Likely pathogenic (Apr 16, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179485178-179485179
- GRCh38:
- Chr2:178620451-178620452
| TTN | M6484fs, M15357fs, M6292fs, M13716fs, M12789fs, M6417fs | Primary dilated cardiomyopathy | Likely pathogenic (Feb 20, 2013) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179485354
- GRCh38:
- Chr2:178620627
| TTN | | Primary dilated cardiomyopathy | Likely pathogenic (Aug 3, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179485441
- GRCh38:
- Chr2:178620714
| TTN | | Primary dilated cardiomyopathy | Likely pathogenic (Jan 28, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179485525
- GRCh38:
- Chr2:178620798
| TTN | L15271*, L6331*, L6398*, L6206*, L12703*, L13630* | Primary dilated cardiomyopathy | Likely pathogenic (Oct 8, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179485573-179485579
- GRCh38:
- Chr2:178620846-178620852
| TTN | Y15253fs, Y6380fs, Y12685fs, Y6313fs, Y13612fs, Y6188fs | Cardiomyopathy | Likely pathogenic (Oct 30, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179485580-179485581
- GRCh38:
- Chr2:178620853-178620854
| TTN | Y15253fs, Y6380fs, Y12685fs, Y13612fs, Y6188fs, Y6313fs | Primary dilated cardiomyopathy | Likely pathogenic (Oct 8, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179485721
- GRCh38:
- Chr2:178620994
| TTN | | Cardiovascular phenotype | Likely pathogenic (Mar 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179489344
- GRCh38:
- Chr2:178624617
| TTN | N13247fs, N14888fs, N5823fs, N6015fs, N12320fs, N5948fs | not provided | Likely pathogenic (Feb 11, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179490032
- GRCh38:
- Chr2:178625305
| TTN | D12271fs, D13198fs, D14839fs, D5774fs, D5899fs, D5966fs | Congenital titinopathy | Likely pathogenic (Apr 24, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179490082-179490083
- GRCh38:
- Chr2:178625355-178625356
| TTN | L13181fs, L5882fs, L5949fs, L12254fs, L14822fs, L5757fs | not provided | Likely pathogenic (Jun 29, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179494980
- GRCh38:
- Chr2:178630253
| TTN | L14757V, L13116V, L5817V, L5692V, L5884V, L12189V | not provided | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:179495000
- GRCh38:
- Chr2:178630273
| TTN | N12182fs, N13109fs, N14750fs, N5685fs, N5810fs, N5877fs | not provided | Likely pathogenic (Jun 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179495076-179495079
- GRCh38:
- Chr2:178630349-178630352
| TTN | E13083fs, E5659fs, E5851fs, E14724fs, E12156fs, E5784fs | Cardiovascular phenotype | Likely pathogenic (Nov 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179495536
- GRCh38:
- Chr2:178630809
| TTN | T14717fs, T5777fs, T5652fs, T12149fs, T13076fs, T5844fs | Cardiovascular phenotype | Likely pathogenic (Jun 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179495542
- GRCh38:
- Chr2:178630815
| TTN | L13074fs, L5842fs, L14715fs, L5775fs, L12147fs, L5650fs | Cardiovascular phenotype | Likely pathogenic (Jun 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179495608
- GRCh38:
- Chr2:178630881
| TTN | R12125fs, R13052fs, R14693fs, R5628fs, R5753fs, R5820fs | not provided | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:179495638-179495639
- GRCh38:
- Chr2:178630911-178630912
| TTN | H12114fs, H14682fs, H5617fs, H5742fs, H13041fs, H5809fs | Cardiovascular phenotype | Likely pathogenic (Nov 12, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179495815
- GRCh38:
- Chr2:178631088
| TTN | Q12086*, Q13013*, Q14654*, Q5589*, Q5714*, Q5781* | Primary familial dilated cardiomyopathy | Likely pathogenic (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179495959
- GRCh38:
- Chr2:178631232
| TTN | Q12038*, Q12965*, Q14606*, Q5541*, Q5733*, Q5666* | Cardiovascular phenotype | Likely pathogenic (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179495983
- GRCh38:
- Chr2:178631256
| TTN | | Primary dilated cardiomyopathy | Likely pathogenic (Oct 8, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179497013-179497014
- GRCh38:
- Chr2:178632286-178632287
| TTN | H14537fs, H5472fs, H5664fs, H5597fs, H12896fs, H11969fs | Primary dilated cardiomyopathy | Likely pathogenic (Jul 6, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179497045
- GRCh38:
- Chr2:178632318
| TTN | R11958*, R12885*, R14526*, R5461*, R5586*, R5653* | not provided | Likely pathogenic (Jan 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179497363
- GRCh38:
- Chr2:178632636
| TTN | K14457fs, K5392fs, K5584fs, K5517fs, K11889fs, K12816fs | not provided | Likely pathogenic (May 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179497406-179497407
- GRCh38:
- Chr2:178632679-178632680
| TTN | G11875fs, G12802fs, G14443fs, G5378fs, G5503fs, G5570fs | Cardiomyopathy | Likely pathogenic (Mar 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179498031-179498032
- GRCh38:
- Chr2:178633304-178633305
| TTN | P12683fs, P14324fs, P5259fs, P5451fs, P5384fs, P11756fs | Primary dilated cardiomyopathy | Likely pathogenic (Jun 10, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179498176-179498177
- GRCh38:
- Chr2:178633449-178633450
| TTN | C12662fs, C5363fs, C14303fs, C5238fs, C5430fs, C11735fs | Dilated cardiomyopathy 1S | Likely pathogenic (May 1, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr2:179498266-179498267
- GRCh38:
- Chr2:178633539-178633540
| TTN | K5209fs, K11706fs, K5334fs, K14274fs, K12633fs, K5401fs | Cardiovascular phenotype | Likely pathogenic (Sep 8, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179498300
- GRCh38:
- Chr2:178633573
| TTN | W12621fs, W5389fs, W14262fs, W5197fs, W11694fs, W5322fs | Cardiovascular phenotype | Likely pathogenic (Aug 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179498591-179498612
- GRCh38:
- Chr2:178633864-178633885
| TTN | L5265fs, L5140fs, L12564fs, L5332fs, L11637fs, L14205fs | Cardiovascular phenotype | Likely pathogenic (May 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179498737-179498740
- GRCh38:
- Chr2:178634010-178634013
| TTN | C14163fs, C11595fs, C5098fs, C5223fs, C12522fs, C5290fs | Cardiovascular phenotype, Cardiomyopathy, Myopathy
| Pathogenic/Likely pathogenic (May 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:179499190-179499193
- GRCh38:
- Chr2:178634463-178634466
| TTN | K5040fs, K11537fs, K5232fs, K12464fs, K14105fs, K5165fs | Primary familial dilated cardiomyopathy | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:179499354
- GRCh38:
- Chr2:178634627
| TTN | I14052fs, I5179fs, I11484fs, I12411fs, I4987fs, I5112fs | Cardiovascular phenotype | Likely pathogenic (Jan 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179500216
- GRCh38:
- Chr2:178635489
| TTN | Y13945*, Y11377*, Y12304*, Y5072*, Y4880*, Y5005* | Primary dilated cardiomyopathy | Likely pathogenic (Oct 8, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179500689
- GRCh38:
- Chr2:178635962
| TTN | | Dilated cardiomyopathy 1G | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:179500831
- GRCh38:
- Chr2:178636104
| TTN | P11255A, P12182A, P13823A, P4758A, P4883A, P4950A | Tip-toe gait | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:179500851
- GRCh38:
- Chr2:178636124
| TTN | G12175fs, G4751fs, G13816fs, G4876fs, G11248fs, G4943fs | Primary dilated cardiomyopathy | Likely pathogenic (Oct 8, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179500915
- GRCh38:
- Chr2:178636188
| TTN | G13795*, G4730*, G4855*, G4922*, G11227*, G12154* | not provided | Likely pathogenic (Sep 27, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179500930-179500931
- GRCh38:
- Chr2:178636203-178636204
| TTN | V12149fs, V4725fs, V13790fs, V4850fs, V11222fs, V4917fs | Cardiovascular phenotype | Likely pathogenic (Jun 6, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179501331-179501334
- GRCh38:
- Chr2:178636604-178636607
| TTN | E4642fs, E11139fs, E12066fs, E4767fs, E4834fs, E13707fs | Cardiovascular phenotype | Likely pathogenic (Feb 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179505302-179505303
- GRCh38:
- Chr2:178640575-178640576
| TTN | R10997fs, R11924fs, R13565fs, R4500fs, R4625fs, R4692fs | Dilated cardiomyopathy 1G | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:179505328
- GRCh38:
- Chr2:178640601
| TTN | E10987*, E11914*, E13555*, E4490*, E4615*, E4682* | Familial cancer of breast | Likely pathogenic (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179505358
- GRCh38:
- Chr2:178640631
| TTN | | not provided | Likely pathogenic (Jun 10, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179505974-179505975
- GRCh38:
- Chr2:178641247-178641248
| TTN | P4670fs, P13543fs, P4478fs, P10975fs, P11902fs, P4603fs | Dilated cardiomyopathy 1G | Likely pathogenic (Sep 20, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179505980
- GRCh38:
- Chr2:178641253
| TTN | K13541*, K10973*, K4601*, K4476*, K11900*, K4668* | not provided | Likely pathogenic (Nov 7, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179505993
- GRCh38:
- Chr2:178641266
| TTN | K10968fs, K11895fs, K13536fs, K4471fs, K4596fs, K4663fs | Primary dilated cardiomyopathy | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:179505998
- GRCh38:
- Chr2:178641271
| TTN | K10967*, K11894*, K13535*, K4470*, K4595*, K4662* | not provided | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:179506982-179506985
- GRCh38:
- Chr2:178642255-178642258
| TTN | E4573fs, E10945fs, E13513fs, E11872fs, E4640fs, E4448fs | Cardiomyopathy | Likely pathogenic (Nov 24, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179511270-179511271
- GRCh38:
- Chr2:178646543-178646544
| TTN | Y13414fs | Early-onset myopathy with fatal cardiomyopathy | Pathogenic (Jan 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179514069
- GRCh38:
- Chr2:178649342
| TTN | | Autosomal recessive limb-girdle muscular dystrophy type 2J, Myopathy, myofibrillar, 9, with early respiratory failure, Dilated cardiomyopathy 1G, Early-onset myopathy with fatal cardiomyopathy, Tibial muscular dystrophy, Hypertrophic cardiomyopathy 9, Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G, not provided
| Pathogenic/Likely pathogenic (Mar 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:179517203
- GRCh38:
- Chr2:178652476
| TTN | E10603*, E11530*, E13037* | Autosomal recessive limb-girdle muscular dystrophy type 2J | Pathogenic (Sep 8, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr2:179517660
- GRCh38:
- Chr2:178652933
| TTN | | not provided | Likely pathogenic (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179517989
- GRCh38:
- Chr2:178653262
| TTN | K12923* | Early-onset myopathy with fatal cardiomyopathy | Likely pathogenic (May 3, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179518019
- GRCh38:
- Chr2:178653292
| TTN | E12913* | Autosomal recessive limb-girdle muscular dystrophy type 2J, TTN-Related Disorders, not provided
| Pathogenic/Likely pathogenic (Jun 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:179518196-179518200
- GRCh38:
- Chr2:178653469-178653473
| TTN | K12887fs | CAP-congenital myopathy with arthrogryposis multiplex congenita without heart involvement | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:179518794
- GRCh38:
- Chr2:178654067
| TTN | E12804fs | TTN-Related Disorders | Likely pathogenic (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179519496
- GRCh38:
- Chr2:178654769
| TTN | K12728* | Dilated cardiomyopathy 1G | Likely pathogenic (Nov 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179522462
- GRCh38:
- Chr2:178657735
| TTN | K12636* | not provided | Pathogenic (May 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179526741
- GRCh38:
- Chr2:178662014
| TTN | Q12379* | not provided | Pathogenic (Jun 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179530520
- GRCh38:
- Chr2:178665793
| TTN | | not provided | Likely pathogenic (May 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179535877
- GRCh38:
- Chr2:178671150
| TTN | I10449fs, I11376fs, I11750fs | not provided | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179536884
- GRCh38:
- Chr2:178672157
| TTN | E10380*, E11681*, E11307* | Autosomal recessive limb-girdle muscular dystrophy type 2J | Pathogenic (Dec 3, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179537142
- GRCh38:
- Chr2:178672415
| TTN | P10340fs, P11641fs, P11267fs | Early-onset myopathy with fatal cardiomyopathy | Pathogenic (May 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179540694
- GRCh38:
- Chr2:178675967
| TTN | K10197fs, K11124fs, K11470fs | not provided | Likely pathogenic (Sep 1, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179542362
- GRCh38:
- Chr2:178677635
| TTN | P10182fs, P11109fs, P11426fs | not provided | Likely pathogenic (Nov 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179542362-179542386
- GRCh38:
- Chr2:178677635-178677659
| TTN | L10174fs, L11101fs, L11418fs | Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J | Likely pathogenic (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179544666
- GRCh38:
- Chr2:178679939
| TTN | E10862fs, E11179fs, E9935fs | not provided | Likely pathogenic (Mar 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179546121
- GRCh38:
- Chr2:178681394
| TTN | K10760*, K11077*, K9833* | not provided | Likely pathogenic (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179547999
- GRCh38:
- Chr2:178683272
| TTN | V10626fs, V10943fs, V9699fs | not provided | Likely pathogenic (Sep 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179549114
- GRCh38:
- Chr2:178684387
| TTN | Q10572*, Q10889*, Q9645* | not provided | Likely pathogenic (Nov 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179549117
- GRCh38:
- Chr2:178684390
| TTN | T10571fs, T10888fs, T9644fs | not provided | Pathogenic (Jun 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179549977
- GRCh38:
- Chr2:178685250
| TTN | | not provided | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:179549998
- GRCh38:
- Chr2:178685271
| TTN | E10501*, E10818*, E9574* | Desmin-related myofibrillar myopathy | Likely pathogenic (Feb 1, 2013) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179550326
- GRCh38:
- Chr2:178685599
| TTN | | Centronuclear myopathy | Pathogenic (Apr 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179552909
- GRCh38:
- Chr2:178688182
| TTN | G10430D, G10747D, G9503D | Tip-toe gait | Likely pathogenic (Feb 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179554281-179554290
- GRCh38:
- Chr2:178689554-178689563
| TTN | E10310fs, E10627fs, E9383fs | not provided | Likely pathogenic (Sep 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179560764-179560765
- GRCh38:
- Chr2:178696037-178696038
| TTN | | not provided | Pathogenic (Oct 23, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179566913-179566922
- GRCh38:
- Chr2:178702186-178702195
| TTN | T10162fs, T8918fs, T9845fs | Primary dilated cardiomyopathy | Likely pathogenic (Jun 7, 2013) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179567361
- GRCh38:
- Chr2:178702634
| TTN | Q10085*, Q8841*, Q9768* | not provided | Likely pathogenic (Jul 31, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179569135
- GRCh38:
- Chr2:178704408
| TTN | | Congenital titinopathy, Early-onset myopathy with fatal cardiomyopathy | Pathogenic (Feb 11, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr2:179569329
- GRCh38:
- Chr2:178704602
| TTN | T8713I, T9640I, T9957I | Tip-toe gait | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:179571628-179571629
- GRCh38:
- Chr2:178706901-178706902
| TTN | F8456fs, F9383fs, F9700fs | Dilated cardiomyopathy 1G | Pathogenic (Nov 21, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179571661
- GRCh38:
- Chr2:178706934
| TTN | A8444fs, A9371fs, A9688fs | Primary dilated cardiomyopathy | Likely pathogenic (Oct 8, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179575788
- GRCh38:
- Chr2:178711061
| TTN | | Autosomal recessive limb-girdle muscular dystrophy type 2J | Likely pathogenic (Sep 26, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr2:179575962
- GRCh38:
- Chr2:178711235
| TTN | W9334*, W8090*, W9017* | not provided | Likely pathogenic (Dec 1, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179578864-179578865
- GRCh38:
- Chr2:178714137-178714138
| TTN | K7596fs, K8523fs, K8840fs | not provided | Pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179579943
- GRCh38:
- Chr2:178715216
| TTN | G7413fs, G8340fs, G8657fs | not provided | Likely pathogenic (Sep 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179582729
- GRCh38:
- Chr2:178718002
| TTN | S7091*, S8018*, S8335* | not provided | Likely pathogenic (Jun 22, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179584315-179584316
- GRCh38:
- Chr2:178719588-178719589
| TTN | G7968fs, G7651fs | Myopathy | Pathogenic (Aug 5, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179585773
- GRCh38:
- Chr2:178721046
| TTN | S7658*, S6414*, S7341* | not provided | Likely pathogenic (Sep 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179586708
- GRCh38:
- Chr2:178721981
| TTN | Y7561C, Y6317C, Y7244C | not provided | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:179586744
- GRCh38:
- Chr2:178722017
| TTN | S6305*, S7232*, S7549* | not provided | Likely pathogenic (Nov 22, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179586818-179586819
- GRCh38:
- Chr2:178722091-178722092
| TTN | I7207fs, I7524fs, I6280fs | not provided | Likely pathogenic (May 18, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179587034
- GRCh38:
- Chr2:178722307
| TTN | S7494P, S7177P, S6250P | Myopathy, myofibrillar, 9, with early respiratory failure | Likely pathogenic (Oct 8, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179587773
- GRCh38:
- Chr2:178723046
| TTN | E7321K, E6077K, E7004K | Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G | Likely pathogenic (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179590094
- GRCh38:
- Chr2:178725367
| TTN | | Noncompaction cardiomyopathy | Pathogenic (Jan 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179590600
- GRCh38:
- Chr2:178725873
| TTN | S5573fs, S6500fs, S6817fs | Autosomal recessive limb-girdle muscular dystrophy type 2J | Likely pathogenic (Feb 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179590657
- GRCh38:
- Chr2:178725930
| TTN | K5554*, K6481*, K6798* | Hypertrophic cardiomyopathy 9 | Likely pathogenic (Jul 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179593450
- GRCh38:
- Chr2:178728723
| TTN | | not provided | Pathogenic (Jan 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:179593497
- GRCh38:
- Chr2:178728770
| TTN | Q5142*, Q6069*, Q6386* | Dilated cardiomyopathy 1G | Pathogenic (May 28, 2019) | criteria provided, single submitter |